ARTICLE | Company News
Aarhus University Hospital, Exiqon deal
October 12, 2015 7:00 AM UTC
Aarhus granted Exiqon exclusive rights to develop and commercialize two sets of biomarkers related to the diagnosis of prostate cancer via urine and tissue samples. Exiqon said the next step will be t...